350 related articles for article (PubMed ID: 9596676)
21. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
22. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.
Chu P; Wierda WG; Kipps TJ
Blood; 2000 Jun; 95(12):3853-8. PubMed ID: 10845920
[TBL] [Abstract][Full Text] [Related]
23. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
Lewis NR; Pallis M; Russell NH
Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
[TBL] [Abstract][Full Text] [Related]
24. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication.
Sloand EM; Young NS; Kumar P; Weichold FF; Sato T; Maciejewski JP
Blood; 1997 Feb; 89(4):1357-63. PubMed ID: 9028959
[TBL] [Abstract][Full Text] [Related]
25. CD4+ T cell-mediated cytotoxicity toward thyrocytes: the importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone.
Kawakami A; Matsuoka N; Tsuboi M; Koji T; Urayama S; Sera N; Hida A; Usa T; Kimura H; Yokoyama N; Nakashima T; Ishikawa N; Ito K; Kawabe Y; Eguchi K
Lab Invest; 2000 Apr; 80(4):471-84. PubMed ID: 10780664
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway.
Weih F; Ryseck RP; Chen L; Bravo R
Proc Natl Acad Sci U S A; 1996 May; 93(11):5533-8. PubMed ID: 8643610
[TBL] [Abstract][Full Text] [Related]
27. Increase in CD95 (Fas/APO-1)-positive CD4+ and CD8+ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena.
Ogawa S; Sakaguchi K; Takaki A; Shiraga K; Sawayama T; Mouri H; Miyashita M; Koide N; Tsuji T
J Gastroenterol Hepatol; 2000 Jan; 15(1):69-75. PubMed ID: 10719750
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand.
von Bernstorff W; Spanjaard RA; Chan AK; Lockhart DC; Sadanaga N; Wood I; Peiper M; Goedegebuure PS; Eberlein TJ
Surgery; 1999 Jan; 125(1):73-84. PubMed ID: 9889801
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
30. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
31. Disturbed expression of Fas/FasL on CD4(+) and CD8(+)T cells in Behcet's disease, Vogt-Koyanagi-Harada syndrome, and idiopathic anterior uveitis.
Yang P; Ji L; Zhou H; Huang X; Xie C; Jin H; Chen L; Kijlstra A
Ocul Immunol Inflamm; 2001 Sep; 9(3):185-91. PubMed ID: 11815887
[TBL] [Abstract][Full Text] [Related]
32. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
[TBL] [Abstract][Full Text] [Related]
33. Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.
Göthert JR; Eisele L; Klein-Hitpass L; Weber S; Zesewitz ML; Sellmann L; Röth A; Pircher H; Dührsen U; Dürig J
Cancer Immunol Immunother; 2013 Nov; 62(11):1697-1709. PubMed ID: 24022692
[TBL] [Abstract][Full Text] [Related]
34. Ibrutinib for improved chimeric antigen receptor T-cell production for chronic lymphocytic leukemia patients.
Fan F; Yoo HJ; Stock S; Wang L; Liu Y; Schubert ML; Wang S; Neuber B; Hückelhoven-Krauss A; Gern U; Schmitt A; Müller-Tidow C; Dreger P; Schmitt M; Sellner L
Int J Cancer; 2021 Jan; 148(2):419-428. PubMed ID: 32683672
[TBL] [Abstract][Full Text] [Related]
35. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.
Serrano D; Monteiro J; Allen SL; Kolitz J; Schulman P; Lichtman SM; Buchbinder A; Vinciguerra VP; Chiorazzi N; Gregersen PK
J Immunol; 1997 Feb; 158(3):1482-9. PubMed ID: 9013995
[TBL] [Abstract][Full Text] [Related]
36. Expression of FasR, Fas-L and Bcl-2 in CD4+ and CD8+ subpopulations of T lymphocytes in the cord blood of healthy full-term newborns, is gender of influence?
Wasiluk A; Ratomski K; Wnuczko K; Zak J; Szczepański M; Wysocka J; Jasińska EA
Adv Med Sci; 2009; 54(1):99-103. PubMed ID: 19482726
[TBL] [Abstract][Full Text] [Related]
37. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.
Dicker F; Kater AP; Fukuda T; Kipps TJ
Blood; 2005 Apr; 105(8):3193-8. PubMed ID: 15339846
[TBL] [Abstract][Full Text] [Related]
38. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
[TBL] [Abstract][Full Text] [Related]
39. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10.
Lundy SK; Boros DL
Infect Immun; 2002 Feb; 70(2):812-9. PubMed ID: 11796615
[TBL] [Abstract][Full Text] [Related]
40. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]